News | September 20, 2010

Transcatheter VAD Clinical Data Presented at TCT

September 20, 2010 – Transcatheter ventricular assist device (VAD) company Abiomed will highlight its devices at several events during the 2010 Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, Sept, 21-25, at the Washington Convention Center in Washington, D.C.

Abiomed is hosting a three-part breakfast series, featuring updates to the USpella registry, Impella case reviews and real-world applications of its Impella VADs. The update to the USpella registry, a U.S. multicenter observational registry of approximately 351 Impella 2.5 patients, will be presented by William O’Neill, M.D., University of Miami, at the Abiomed breakfast session at 7 a.m. Thursday, Sept. 23, and also presented later that day by Brijeshwar Maini, M.D., Pinnacle Health and Vascular Institute, during TCT “Session III: Optimizing Primary PCI for STEMI in the Cath Lab.”

Abiomed will also conduct daily booth demonstrations at booth 1403 and hands-on simulations of its heart recovery platforms. The company anticipates live cases utilizing Impella to be broadcast from the participating live case sites in the main arena, coronary theater and structural heart theater. Abiomed also anticipates panel discussions on the Impella technology throughout the week.

Wednesday, Sept. 22
TCT 19th Annual Cardiovascular Nurse and Technologist Symposium (Part 2) breakout session I,? room 202A,? Washington Convention Center. From 11:10-11:20 a.m. – “Which Hemodynamic Support Device for Which Patient: IABP and Impella,” presented by Brijeshwar Maini, M.D., Pinnacle Health and Vascular Institute.

Thursday, Sept. 23
• Abiomed-sponsored breakfast sessions are held from 7-8 a.m. Part I: “The Case for Hemodynamic Support: Underlying Science and Clinical Evidence,” ?room 140A,? Washington Convention Center, USpella registry update by William O’Neill, M.D., University of Miami. “The Science of Hemodynamic Support,” John Lasala, M.D., Ph.D., Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis.

• TCT session “Optimizing Primary PCI for STEMI in the Cath Lab,” room 147AB,? Washington Convention Center. From 11:17–11:27 a.m. – “Hemodynamic Support for Shock: Choosing Between IABP, Impella and Tandem Heart,” presented by Vladimir Dzavik, M.D., University Health Network. From 11:27–11:37 a.m. - “Experiences with Impella in STEMI: The USpella study,” presented by Brijeshwar Maini, M.D., Pinnacle Health and Vascular Institute.

Friday, Sept. 24
Abiomed-sponsored breakfast session 7-8 a.m. – Part ll: “Hemodynamic Support Today and in the Future: A Case-Based Review,”? room 140A,? Washington Convention Center. Opening remarks, Srihari Naidu, M.D., Winthrop University Hospital. Case reviews and panel discussion, Salman Arain, M.D., Tulane University Heart & Vascular Institute; Wissam Gharib, M.D., West Virginia University Cardiology, and Mark Grise, M.D., John Ochsner Heart and Vascular Institute. Future directions of Impella, Brijeshwar Maini, M.D., Pinnacle Health and Vascular Institute.

Saturday, Sept. 25
Abiomed-sponsored breakfast session, 7-8 a.m. – Part III: “Impella Case Review of Award-Winning Fellows’ Presentations,”? room 143B,? Washington Convention Center. Opening remarks and “Hospital Impella Experience,” Theodore Schreiber, M.D., DMC Cardiovascular Institute/Harper University Hospital. “Award-Winning Impella Cases,” Schreiber, Neeraj Jolly, M.D., University of Chicago Medical Center and Roxana Mehran, M.D., Mount Sinai Medical Center.

For more information:

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Registry Identifies Early Onset of Heart Failure and Lack of Defibrillators in Asia
News | Heart Failure| August 03, 2017
August 3, 2017 — The Asian Pacific Society of Cardiology (ASPC) held its first-ever late-breaking...
Overlay Init